Yoshiro Maru

Yoshiro Maru

Department of Pharmacology, Tokyo Women's Medical University

Affiliated withTokyo Women's Medical UniversityTokyo Women's Medical University

Research Area

Biography

Yoshiro Maru has not added Biography.
If you are Yoshiro Maru and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Lung Tumor Cell Recruitment Assay
Publication title
2019

Other Publications

Article
Year
Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway.

The Journal of biological chemistry| PubMed ID: 14610081

2004
Tyrosine kinase as molecular target of anti-tumor drug.

Nihon yakurigaku zasshi. Folia pharmacologica Japonica| PubMed ID: 14639001

2003
2004
2005
2005
2005
Expression of Nox genes in rat organs, mouse oocytes, and sea urchin eggs.

DNA sequence : the journal of DNA sequencing and mapping| PubMed ID: 16147858

2005
2006
2006
LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 17351128

2007
2007
[S100A8 and S100A9 regulate lung metastasis].

Seikagaku. The Journal of Japanese Biochemical Society| PubMed ID: 17969327

2007
2008
2008
2008
2009
Which came first, tumor cells or macrophages?

Cell adhesion & migration| PubMed ID: 19329882

2007
2010
XPB induces C1D expression to counteract UV-induced apoptosis.

Molecular cancer research : MCR| PubMed ID: 20530579

2010
2010
2011
2011
Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 21321210

2011
2011
Molecular biology of chronic myeloid leukemia.

Cancer science| PubMed ID: 22632137

2012
2013
Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 23858030

2013
2013
Ephrin-A1 expression induced by S100A8 is mediated by the toll-like receptor 4.

Biochemical and biophysical research communications| PubMed ID: 24103748

2013
2014
2014
2015
Anti-inflammatory Treatment for Seemingly Non-inflammatory Disorders. Editorial.

Endocrine, metabolic & immune disorders drug targets| PubMed ID: 26004772

2015
Drug Targeting Based on a New Concept-Targeting Against TLR4 as an Example.

Endocrine, metabolic & immune disorders drug targets| PubMed ID: 26004773

2015
Editorial: Anti inflammatory Treatment for Seemingly Non-inflammatory Disorders-Part 2.

Endocrine, metabolic & immune disorders drug targets| PubMed ID: 26333725

2015
2015
2016
2016
2016
2018
2018
2018
2018
Roles of EphA1/A2 and ephrin-A1 in cancer.

Cancer science| PubMed ID: 30657619

2019